Sage Journals: Discover world-class research

Abstract

Keywords

ACCF/AHA Performance Measures abdominal aortic aneurysm ankle brachial index peripheral arterial disease secondary prevention supervised exercise

References

Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001 .

Bonow RO , Bennett S. , Casey DE Jr , et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures). J Am Coll Cardiol 2005; 46: 1144-1178.

American Medical Association Physician Consortium for Performance Improvement. Clinical performance measures: chronic stable coronary artery disease, http://www.ama-assn.org/ama1/pub/upload/mm/370/cadminisetjune06.pdf (accessed January 5, 2010).

American Medical Association Physician Consortium for Performance Improvement. Clinical performance measures: hypertension, http://www.ama-assn.org/ama1/pub/upload/mm/370/hypertension-8-05.pdf (accessed January 5, 2010).

Krumholz HM , Anderson JL , Brooks NH , et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2006; 47: 236-265.

Krumholz HM , Anderson JL , Bachelder BL , et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2008; 52: 2046-2099.

Thomas RJ , King M. , Lui K. , et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. J Am Coll Cardiol 2007; 50: 1400-1433.

Thomas RJ , King M. , Lui K. , et al. AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services. J Am Coll Cardiol 2010; 56: 1159-1167.

Estes NA III , Halperin JL , Calkins H. , et al. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with non-valvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation). J Am Coll Cardiol 2008; 51: 865-884.

10.

Redberg RF , Benjamin EJ , Bittner V. , et al. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease). J Am Coll Cardiol 2009; 54: 1364-1405.

11.

Spertus JA , Eagle KA , Krumholz HM , et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 2005; 45: 1147-1156.

12.

Krumholz HM , Brindis RG , Brush JE , et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association scientific statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Circulation 2006; 113: 456-462.

13.

Hirsch AT , Haskal ZJ , Hertzer NR , et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol 2006; 47: e1-192.

14.

Creager MA , White CJ , Hiatt WR , et al. Atherosclerotic Peripheral Vascular Disease Symposium II: executive summary. Circulation 2008; 118: 2811-2825.

15.

Hiatt WR , Goldstone J. , Smith SC Jr , et al. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases. Circulation 2008; 118: 2826-2829.

16.

Rosamond W. , Flegal K. , Furie K. , et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.

17.

Criqui MH , Fronek A. , Barrett-Connor E. , et al. The prevalence of peripheral arterial disease in a defined population . Circulation 1985; 71: 510-515.

18.

Kannel WB , McGee DL Update on some epidemiologic features of intermittent claudiation: the Framingham Study. J Am Geriatr Soc 1985 ; 33: 13-18.

19.

Regensteiner JG , Hiatt WR Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med 2002; 112: 49-57.

20.

Hirsch AT , Criqui MH , Treat-Jacobson D. , et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.

21.

McDermott MM , Greenland P. , Liu K. , et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study . Ann Intern Med 2002 ; 136: 873-883.

22.

Barletta G. , Perna S. , Sabba C. , et al. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med 1996; 1: 3-7.

23.

Khaira HS , Hanger R. , Shearman CP Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 1996; 11: 65-69.

24.

Pell JP Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg 1995 ; 9: 469-472.

25.

Ponte E. , Cattinelli S. Quality of life in a group of patients with intermittent claudication . Angiology 1996; 47: 247-251.

26.

Treat-Jacobson D. , Halverson S. , Ratchford A. , et al. A patient-derived perspective of health-related quality-of-life in peripheral arterial disease . J Nurs Scholarsh 2002; 34: 55-60.

27.

Smolderen KG , Aquarius AE , de Vries J. , et al. Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors . J Affect Disord 2008; 110: 27-35.

28.

Vogt MT , Cauley JA , Newman AB , et al. Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA 1993; 270: 465-469.

29.

McKenna M. , Wolfson S. , Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991; 87: 119-128.

30.

Newman AB , Shemanski L. , Manolio TA , et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 538-545.

31.

Criqui MH , Coughlin SS , Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality: results from a prospective study. Circulation 1985; 72: 768-773.

32.

Newman AB , Tyrrell KS , Kuller LH Mortality over four years in SHEP participants with a low ankle-arm index . J Am Geriatr Soc 1997; 45: 1472-1478.

33.

Resnick HE , Lindsay RS , McDermott MM , et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004; 109: 733-739.

34.

Criqui MH , Langer RD , Fronek A. , et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-386.

35.

Leng GC , Lee AJ , Fowkes FG , et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172-1181.

36.

Criqui MH , Denenberg JO , Langer RD , et al. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997; 2: 221-226.

37.

Ness J. , Aronow WS Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1999; 47: 1255-1256.

38.

Zheng ZJ , Sharrett AR , Chambless LE , et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997; 131: 115-125.

39.

Burek KA , Sutton-Tyrrell K. , Brooks MM , et al. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 1999 ; 34: 716-721.

40.

Saw J. , Bhatt DL , Moliterno DJ , et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol 2006 ; 48: 1567-1572.

41.

Norgren L. , Hiatt WR , Dormandy JA , et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 Suppl 1: 1-75.

42.

Normand SL , McNeil BJ , Peterson LE , et al. Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. Int J Qual Health Care 1998; 10: 247-260.

43.

Steg PG , Bhatt DL , Wilson PW , et al. One-year cardiovascular event rates in outpatients with atherothrombosis . JAMA 2007; 297: 1197-1206.

44.

Diehm C. , Lange S. , Darius H. , et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006; 27: 1743-1749.

45.

Selvin E. , Hirsch AT Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis 2008; 201: 425-433.

46.

Feringa HH , van Waning VH , Bax JJ , et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol 2006; 47: 1182-1187.

47.

McDermott MM , Hahn EA , Greenland P. , et al. Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med 2002; 17: 895-904.

48.

McDermott MM , Mandapat AL , Moates A. , et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med 2003; 163: 2157-2162.

49.

Perlstein TS , Creager MA The ankle-brachial index as a biomarker of cardiovascular risk: it’s not just about the legs. Circulation 2009; 120: 2033-2035.

50.

Fowkes FG , Murray GD , Butcher I. , et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197-208.

51.

Berger JS , Krantz MJ , Kittelson JM , et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 2009; 301: 1909-1919.

52.

Fowkes FG , Price JF , Stewart MC , et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 2010; 303: 841-848.

53.

Hiatt WR Medical treatment of peripheral arterial disease and claudication . N Engl J Med 2001; 344: 1608-1621.

54.

Stewart KJ , Hiatt WR , Regensteiner JG , et al. Exercise training for claudication. N Engl J Med 2002; 347: 1941-1951.

55.

Bandyk DF , Schmitt DD , Seabrook GR , et al. Monitoring functional patency of in situ saphenous vein bypasses: the impact of a surveillance protocol and elective revision. J Vasc Surg 1989; 9: 286-296.

56.

Lundell A. , Lindblad B. , Bergqvist D. , et al. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg 1995; 21: 26-33.

57.

Davies AH , Hawdon AJ , Sydes MR , et al. Is Duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation 2005; 112: 1985-1991.

58.

Cooper CJ , Murphy TP , Matsumoto A. , et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006; 152: 59-66.

59.

National Diabetes Quality Improvement Alliance. Performance measurement set for adult diabetes, http://www.-nehc.med.navy.mil/bumed/diabetes/document%20folders/diabetes/cpg/dqia.msrs.pdf (accessed January 5, 2010).

60.

National Quality Forum. National voluntary consensus standards for ambulatory care: diabetes care measures, http://www.qualityforum.org/Publications/2008/03/National_Voluntary_Consensus_Standards_for_Ambulatory_Care%E2%80%93Part_2.aspx (accessed December 24, 2009).

61.

Fleming C. , Whitlock EP , Beil TL , et al. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2005; 142: 203-211).

62.

Kent KC , Zwolak RM , Jaff MR , et al. Screening for abdominal aortic aneurysm: a consensus statement . J Vasc Surg 2004; 39: 267-269.

63.

Screening for abdominal aortic aneurysm recommendation statement . Ann Intern Med 2005; 142: 198-202.

64.

Ashton HA , Gao L. , Kim LG , et al. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg 2007; 94: 696-701.

65.

Cosford PA , Leng GC Screening for abdominal aortic aneurysm. CD002945 Cochrane Database Syst Rev 2007;CD002945.

66.

Lindholt JS , Norman P. Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the mid- and long-term effects of screening for abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2008; 36: 167-171.

67.

Kim LG , Scott Rap , Ashton HA , et al. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007; 146: 699-706.

68.

Olin JW Long-term outcomes and cost-effectiveness of screening for abdominal aortic aneurysm. Nat Clin Pract Cardiovasc Med 2007 ; 4: 650-651.

69.

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.

70.

Smith SC Jr , Allen J. , Blair SN , et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. J Am Coll Cardiol 2006; 47: 2130-2139.

71.

The Vascular Disease Foundation (VDF) and the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). P.A.D. exercise training toolkit: a guide for health care professionals, http://www.vdf.org/professionals/exercisetoolkit.php (accessed May 25, 2010).

72.

American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription, 7th edition. Baltimore, MD: Lippincott Williams & Wilkins, 2006.

73.

Penchansky R. , Thomas JW The concept of access: definition and relationship to consumer satisfaction. Med Care 1981; 19: 127-140.

ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease

Abstract

Keywords

References